Sign in
8-K

Current Report

Vaxart, Inc. Filed Acc 0001437749-13-015134

Exit or restructuring costs

  • Item 2.05 Costs associated with exit or disposal activities

From the SEC's structured data for this filing

Loading bota20131121_8k.htm…